Clinical ResearchComparison of Titanium-Nitride-Oxide–Coated Stents With Zotarolimus-Eluting Stents for Coronary Revascularization: A Randomized Controlled Trial
Under an Elsevier user license
open archive
Key Words
passive stent coating
titanium-nitride-oxide–coated stent(s)
zotarolimus-eluting stent(s)
Abbreviations and Acronyms
CI
confidence interval
CK
creatine kinase
DES
drug-eluting stent(s)
IQR
interquartile range
TiNO
titanium-nitride-oxide
TLR
target lesion revascularization
ZES
zotarolimus-eluting stent(s)
Cited by (0)
Supported by the Inselspital Foundation. Dr. Jüni is an unpaid member of steering groups and planning committees of cardiovascular trials funded by Abbott Vascular, Biosensors, Cordis, Medtronic, and St. Jude Medical. Dr. Windecker received research grants from Abbott, Cordis, Medtronic, Biosensors, and Biotronik. All other authors have reported that they have no relationships to disclose. Drs. Pilgrim and Räber contributed equally to this work. Sotirios Tsimikas, MD, served as Guest Editor for this paper, and this paper was accepted before he became a new Associate Editor.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.